These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24324051)

  • 21. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications.
    López B; González A; Querejeta R; Barba J; Díez J
    J Hypertens; 2009 Feb; 27(2):418-24. PubMed ID: 19155793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives?
    Cuspidi C; Meani S; Negri F; Giudici V; Valerio C; Sala C; Zanchetti A; Mancia G
    J Hum Hypertens; 2009 Nov; 23(11):728-34. PubMed ID: 19322202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension.
    Moreno MU; San José G; Fortuño A; Beloqui O; Díez J; Zalba G
    J Hypertens; 2006 Jul; 24(7):1299-306. PubMed ID: 16794479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
    Kjaer A; Meyer C; Wachtell K; Olsen MH; Ibsen H; Opie L; Holm S; Hesse B
    Am J Cardiol; 2005 Dec; 96(12):1692-8. PubMed ID: 16360359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart failure in hypertensive patients with left ventricular hypertrophy].
    Ghanem Wisam MA; Mikes P; Bulas J; Kozlíková K; Sleiman O; Murín J; Reptová A
    Vnitr Lek; 2001 Jun; 47(6):348-53. PubMed ID: 11494879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.
    San José G; Moreno MU; Oliván S; Beloqui O; Fortuño A; Díez J; Zalba G
    Hypertension; 2004 Aug; 44(2):163-9. PubMed ID: 15210651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?
    Cuspidi C; Esposito A; Negri F; Sala C; Masaidi M; Giudici V; Zanchetti A; Mancia G
    Am J Hypertens; 2008 Apr; 21(4):458-63. PubMed ID: 18369363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy.
    Passino C; Franzoni F; Gabutti A; Poletti R; Galetta F; Emdin M
    Int J Cardiol; 2004 Oct; 97(1):57-62. PubMed ID: 15336807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension.
    Fortuño A; Bidegain J; Robador PA; Hermida J; López-Sagaseta J; Beloqui O; Díez J; Zalba G
    Hypertension; 2009 Oct; 54(4):744-50. PubMed ID: 19687351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.
    Cerasola G; Nardi E; Mulè G; Palermo A; Cusimano P; Guarneri M; Arsena R; Giammarresi G; Carola Foraci A; Cottone S
    Nephrology (Carlton); 2010 Mar; 15(2):203-10. PubMed ID: 20470280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
    Parrinello G; Licata A; Colomba D; Di Chiara T; Argano C; Bologna P; Corrao S; Avellone G; Scaglione R; Licata G
    J Hum Hypertens; 2005 Jul; 19(7):543-50. PubMed ID: 15944724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heart rate variability in patients with hypertension and left ventricular hypertrophy].
    Stolarz K; Olszanecka A; Rajzer M; Lubaszewski W; Kawecka-Jaszcz K
    Przegl Lek; 2002; 59(9):703-5. PubMed ID: 12632890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch.
    Pemberton CJ; Raudsepp SD; Yandle TG; Cameron VA; Richards AM
    Cardiovasc Res; 2005 Oct; 68(1):109-17. PubMed ID: 15978561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension.
    López B; Castellano JM; González A; Barba J; Díez J
    Hypertension; 2007 Nov; 50(5):977-83. PubMed ID: 17846346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition.
    Ferrara LA; Vaccaro O; Cardoni O; Laurenzi M; Mancini M; Zanchetti A
    Am J Hypertens; 2005 Oct; 18(10):1282-7. PubMed ID: 16202849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.